Date |
Title |
Meeting/Publication |
Link |
November 13-16, 2020 |
KB39, a novel synthetic glycan modulating the gut microbiome, decreases fatty liver and atherosclerosis in diet-induced murine models of non-alcoholic fatty liver and cardiovascular disease |
The Liver Meeting Digital Experience | AASLD |
Click here
|
November 13-16, 2020 |
Community shift in the gut microbiome is a potential mechanism for reduction in gut microbiota-associated ammonia by the novel synthetic glycan, KB174, in patients with well-compensated cirrhosis |
The Liver Meeting Digital Experience | AASLD |
Click here
|
Oct. 21-25, 2020 |
Development of a Novel Synthetic Glycan to Prevent Bacterial Infections and Ameliorate Respiratory Viral Infections |
IDWeek 2020™ |
Click here
|
August 27-29, 2020 |
KB174 Reduces Relative Abundance of Multidrug Resistant (MDR) Enterobacteriaceae in Fecal Samples From Patients With Cirrhosis in an Ex Vivo Assay |
The Digital International Liver Congress™ 2020 |
Click here
|
August 27-29, 2020 |
A Randomized, Double-Blind Study to Evaluate the Safety and Tolerability of KB174, a Novel Synthetic Glycan, in Patients With Well-Compensated Cirrhosis |
The Digital International Liver Congress™ 2020 |
Click here
|
August 27-29, 2020 |
Microbiome Metabolic Therapies Reduce Microbiota-Associated Ammonia in Ex Vivo Fecal Samples From Healthy Subjects and Patients With Minimal Hepatic Encephalopathy and Demonstrate Improved Tolerability Over Lactulose in a Clinical Study |
The Digital International Liver Congress™ 2020 |
Click here
|
October 6-10, 2019 |
Chemical Modulation of the Gut Microbiome Alleviates Chemotherapy-Induced Toxicity |
Keystone Symposia on Molecular and Cellular Biology I Microbiome: Therapeutic Implications |
Click here
|
October 2-6, 2019 |
Novel Glycans Reduce Carbapenem-resistant Enterobacteriaceae (CRE) and Vancomycin-resistant Enterococcus (VRE) Colonization in an Ex Vivo Assay by Supporting Growth of Commensal Microbiota at the Expense of Multidrug-Resistant (MDR) Organisms |
IDWeek 2019™ |
Click here
|
September 3-6, 2019 |
An Open-Label, Single-Arm Clinical Study to Evaluate Safety and Tolerability of KB195, A Novel Glycan, in Patients with Urea Cycle Disorders |
SSIEM/ Society for the Study of Inborn Errors of Metabolism Annual Symposium |
Click here
|
April 12, 2019 |
Identification of Novel Glycans That Target Gut Microbiota-Associated Ammonia Production |
EASL | The International Liver Congress™ 2019 |
Click here
|
April 7, 2019 |
KB195, a Novel Glycan, Modulates Ammonia Metabolism in Healthy Subjects and in Microbiome Samples Collected From Patients With Urea Cycle Disorders |
Society for Inherited Metabolic Disorders (SIMD), 41st Annual Meeting |
Click here
|
March 12, 2019 |
Developing a Drug Discovery Platform to Target Gut Microbiota-Associated Ammonia Production |
Keystone Symposia, Microbiome: Chemical Mechanisms and Biological Consequences |
Click here
|
September 18, 2018 |
Microbiome Metabolic Therapies (MMTs) reduce pathogen colonization in ex vivo testing of intensive care unit patient microbiomes |
EMBO | EMBL Symposium: The Human Microbiome |
Click here
|
Date |
Title |
Meeting/Publication |
Link |
February 11, 2020 |
Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth |
Cell Reports |
Click here
|
July 22, 2019 |
Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response |
Nature Communications |
Click here
|
December 10, 2018 |
Gut microbiome structure and metabolic activity in inflammatory bowel disease |
Nature Microbiology |
Click here
|
November 5, 2018 |
Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels |
Gut Microbes |
Click here
|
June 28, 2018 |
Impact of gut colonization with butyrate producing microbiota on respiratory viral infection following allo-HCT |
Blood |
Click here
|
May 15, 2018 |
Dietary Fiber Confers Protection against Flu by Shaping Ly6c- Patrolling Monocyte Hematopoiesis and CD8+T Cell Metabolism |
Immunity |
Click here
|
January 5, 2018 |
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors |
Science |
Click here
|
November 25, 2014 |
A perspective on the complexity of dietary fiber structures and their potential effect on the gut microbiota |
Journal of Molecular Biology |
Click here
|
April 24, 2013 |
Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk |
New England Journal of Medicine |
Click here
|
April 11, 2012 |
How glycan metabolism shapes the human gut microbiota |
Nature Reviews Microbiology |
Click here
|
March 29, 2011 |
Microbiota regulates immune defense against respiratory tract influenza A virus infection |
Proceedings of the National Academy of Sciences |
Click here
|
March 11, 2006 |
Effect of lactulose and Saccharomyces boulardii administration on the colonic urea‐nitrogen metabolism and the bifidobacteria concentration in healthy human subjects |
Alimentary Pharmacology & Therapeutics |
Click here
|